These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3934807)

  • 1. The effect of anti-interleukin-2 receptor monoclonal antibody on allograft rejection.
    Kirkman RL; Barrett LV; Gaulton GN; Kelley VE; Koltun WA; Schoen FJ; Ythier A; Strom TB
    Transplantation; 1985 Dec; 40(6):719-22. PubMed ID: 3934807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Administration of an anti-interleukin 2 receptor monoclonal antibody prolongs cardiac allograft survival in mice.
    Kirkman RL; Barrett LV; Gaulton GN; Kelley VE; Ythier A; Strom TB
    J Exp Med; 1985 Jul; 162(1):358-62. PubMed ID: 3925068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapy with monoclonal antibody to interleukin 2 receptor spares suppressor T cells and prevents or reverses acute allograft rejection in rats.
    Kupiec-Weglinski JW; Diamantstein T; Tilney NL; Strom TB
    Proc Natl Acad Sci U S A; 1986 Apr; 83(8):2624-7. PubMed ID: 2939456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of suppressor lymphocytes during acute rejection of rat cardiac allografts and preservation of suppression by anti-IL-2-receptor monoclonal antibody.
    Schneider TM; Kupiec-Weglinski JW; Towpik E; Padberg W; Araneda D; Diamantstein T; Strom TB; Tilney NL
    Transplantation; 1986 Aug; 42(2):191-6. PubMed ID: 2943063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolongation of murine skin allograft survival by immunologic manipulation with anti-interleukin 2 receptor antibody.
    Granstein RD; Goulston C; Gaulton GN
    J Immunol; 1986 Feb; 136(3):898-902. PubMed ID: 3079802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous blockade of co-stimulatory signals, CD28 and ICOS, induced a stable tolerance in rat heart transplantation.
    Guo L; Fujino M; Kimura H; Funeshima N; Kitazawa Y; Harihara Y; Tezuka K; Makuuchi M; Suzuki S; Li XK
    Transpl Immunol; 2003; 12(1):41-8. PubMed ID: 14551031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-CD2 and anti-CD3 monoclonal antibodies synergize to prolong allograft survival with decreased side effects.
    Chavin KD; Qin L; Lin J; Kaplan AJ; Bromberg JS
    Transplantation; 1993 Apr; 55(4):901-8. PubMed ID: 8097344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged murine cardiac allograft acceptance: characteristics of persistent active alloimmunity after treatment with gallium nitrate versus anti-CD4 monoclonal antibody.
    Orosz CG; Wakely E; Sedmak DD; Bergese SD; VanBuskirk AM
    Transplantation; 1997 Apr; 63(8):1109-17. PubMed ID: 9133472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling.
    Orosz CG; Huang EH; Bergese SD; Sedmak DD; Birmingham DJ; Ohye RG; VanBuskirk AM
    J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An agonistic anti-BTLA mAb (3C10) induced generation of IL-10-dependent regulatory CD4+ T cells and prolongation of murine cardiac allograft.
    Uchiyama M; Jin X; Matsuda H; Bashuda H; Imazuru T; Shimokawa T; Yagita H; Niimi M
    Transplantation; 2014 Feb; 97(3):301-9. PubMed ID: 24448587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of IL 2R+ T cells and macrophages within rejecting rat cardiac allografts, and comparison of the effects of treatment with anti-IL 2R monoclonal antibody or cyclosporin.
    Hancock WW; Lord RH; Colby AJ; Diamantstein T; Rickles FR; Dijkstra C; Hogg N; Tilney NL
    J Immunol; 1987 Jan; 138(1):164-70. PubMed ID: 3097143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective blockade of IL-15 by soluble IL-15 receptor alpha-chain enhances cardiac allograft survival.
    Smith XG; Bolton EM; Ruchatz H; Wei X; Liew FY; Bradley JA
    J Immunol; 2000 Sep; 165(6):3444-50. PubMed ID: 10975865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of the IL-2 pathway in costimulation blockade-resistant rejection of allografts.
    Jones TR; Ha J; Williams MA; Adams AB; Durham MM; Rees PA; Cowan SR; Pearson TC; Larsen CP
    J Immunol; 2002 Feb; 168(3):1123-30. PubMed ID: 11801646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-6 receptor signaling disruption prevents cardiac allograft deterioration in mice.
    Iida S; Omoto K; Kanemitsu I; Setoguchi K; Ishida H; Tanabe K; Suzuki T; Tashiro Y; Kishimoto H; Abe R
    Exp Clin Transplant; 2012 Aug; 10(4):375-85. PubMed ID: 22758208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic administration of anti-interleukin-10 antibody prolongs organ allograft survival in normal and presensitized recipients.
    Li W; Fu F; Lu L; Narula SK; Fung JJ; Thomson AW; Qian S
    Transplantation; 1998 Dec; 66(12):1587-96. PubMed ID: 9884244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of exogenous interleukin-10 on cardiac allograft survival: inhibition of rejection by recipient pretreatment reflects impaired host accessory cell function.
    Li W; Fu F; Lu L; Narula SK; Fung JJ; Thomson AW; Qian S
    Transplantation; 1999 Nov; 68(9):1402-9. PubMed ID: 10573082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective immunosuppression with anti-interleukin 2 receptor-targeted therapy: helper and suppressor cell activity in rat recipients of cardiac allografts.
    Kupiec-Weglinski JW; Padberg W; Uhteg LC; Ma L; Lord RH; Araneda D; Strom TB; Diamantstein T; Tilney NL
    Eur J Immunol; 1987 Mar; 17(3):313-9. PubMed ID: 2952511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokines regulate the pattern of rejection and susceptibility to cyclosporine therapy in different mouse recipient strains after cardiac allografting.
    Wang H; Hosiawa KA; Min W; Yang J; Zhang X; Garcia B; Ichim TE; Zhou D; Lian D; Kelvin DJ; Zhong R
    J Immunol; 2003 Oct; 171(7):3823-36. PubMed ID: 14500684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
    Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
    J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trichinella spiralis infection changes immune response in mice performed abdominal heterotopic cardiac transplantation and prolongs cardiac allograft survival time.
    Deng G; Deng R; Yao J; Liao B; Chen Y; Wu Z; Hu H; Zhou X; Ma Y
    Parasitol Res; 2016 Jan; 115(1):407-14. PubMed ID: 26481486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.